发明申请
- 专利标题： Methods for glucagon suppression using modified exendins
- 专利标题（中）： 使用改良的毒蜥外泌肽抑制胰高血糖素的方法
-
申请号： US11584114申请日： 2006-10-19
-
公开(公告)号： US20070037750A1公开(公告)日： 2007-02-15
- 发明人: Andrew Young , Bronislava Gedulin
- 申请人： Andrew Young , Bronislava Gedulin
- 申请人地址： US CA San Diego 92121
- 专利权人： Amylin Pharmaceuticals, Inc.
- 当前专利权人： Amylin Pharmaceuticals, Inc.
- 当前专利权人地址： US CA San Diego 92121
- 主分类号： A61K38/22
- IPC分类号： A61K38/22
摘要：
Methods for use of an exendin, an exendin agonist, or a modified exendin or exendin agonist having an exendin or exendin agonist linked to one or more polyethylene glycol polymers, for example, for lowering glucagon levels and/or suppressing glucagon secretion in a subject are provided. These methods are are useful in treating hyperglucagonemia and other conditions that would be benefited by lowering plasma glucgon or suppressing glucagon secretion.
公开/授权文献
- US07407932B2 Methods for glucagon suppression using modified exendins 公开/授权日：2008-08-05
信息查询
IPC分类:
